In continuation of the Company''s letter dated 30/Oct/2026 (ref. no. SPIL/CS/2026-2027/72), the Board of Directors at its Meeting held on 29/Oct/2026 have approved the proposal to raising of funds through issue and allotment of Convertible Warrants upto an amount not exceeding Rs.72 Crores, each warrant convertible into 1 equity share of Re1/- each, on a preferential basis to Mr. Hemal Mehta and Mr. Sachin Mehta, Promoters of the Company. The ....

OUDAREHAT PHARIIA IIIDUOTRIES TT] Head Otfice : 301 . Aura Bip ex, Premium Reta I Prem ses. 7 S V Boad, Bor vali (West). [,4umbai - 400092 E-mail :comp ance@s!darshanpharma.corn . Website: www.sudarshanpharma.com Board Lihe : +91-22.42221111 I 43331111 i 42221116 fi 00 line) . CIN : Lsl4g6tvlH2OOBPLC 184997 sP tL / cs / sE / 2026 -2027 / 7 3 Date: 30th October 2026 The Listing Depa*ment The Listing Department BSE Limited NationalSto.k Exchange of India Limited Phiroze lee.jeebhoy Towers, Exchange Plaza, C-1, BlockG, DalalStreet, Bandra Kurla Complex, Bandra (E), Mumbai- 400 001 N4umbai- 400 051 BSE Scrip Code: 543828 NSE Trading Symbol: SUDARSHAN Ref: ReBulation 30 ofSEBl (Listing Obligations And Disclosure Requirements) Regu lations, 2Ol5 Sub: Update on Outcome of the Meeting of Board of Directors of the Company held on Thursday, 29th October, 2026 Dear Sir / Madam, In continuation of the Company,s communication dated 3oth October 2026 (ref. no. SPI|/CS/SE/2026-2O27/72), this is to inform you that the Board of Directors of the Company at its Board meeting held on 29th October, 2026 has approved the proposal to raising of funds through issue and allotment oi Convertible Warrants upto an amount not exceeding RS.72,OO,OO,OOO/_ (Rupees Seventy Two Crores only), each Warrant convertible into 1 (one) Equity Share of the Face Value of Re.1/- (Rupee One On-ly) in terms of Chapter V of the SEBj (lssue of Capital and Disclosure Requirements) Regulations,2018, as amended (,,SEB| ICDR Regulations,,) on a preferential basis to Mr. Hemal Mehta and Mr. Sachin Mehta, promoters ofthe Company. The Warrants shai be lssued at a price to be determined as per Regulation 164 ofthe SEBI ICDR Regulat ons, sublect to the approval of regu atory / statutory authorities and the members of the Company at an Extraord nary cener.l Meettng ("EGM,,). The tsoard will be seeking shareholders' approval in an EGIU, Notice of which will be issued separate y. The meeting ofthe Board of Directors commencecl at 7.OO pm and concluded at 10.00 pnr We request you to kindly take the above information on record. Thanks & Regards, Yours falthfully, For Sudarshan Pharma I mited Sachin N4ehta Jo int ManaginB Dl Begd. Ofi. : 301, Aura Biplex, Above Kalyan Jewellers, S.V Road, Borivali (West)i l\4umbai -400092